1. Stimulus bill packs a windfall for FDA and COVID-19 drug developers — Roche nixes Tecentriq bladder cancer accelerated approval — AI uncovers Lilly's Olumiant as potential Alzheimer's treatment See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Millennium CEO of the Year Semifinalist

Discussion in 'Millennium Laboratories' started by Anonymous, May 5, 2011 at 5:28 PM.

  1. Anonymous

    Anonymous Guest

    Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year(R) 2011 Award Semifinalist in San Diego Slattery Joins Prestigious List of Ernst & Young Semifinalists
    Published: Monday, 25 Apr 2011 | 6:00 AM ET Text Size
    SAN DIEGO, April 25, 2011 /PRNewswire via COMTEX/ -- Millennium Laboratories, a leading provider of prescription drug monitoring services and education to physicians and staff treating chronic pain, announced today that the company's founder and CEO James Slattery has been named as a semifinalist for the Ernst & Young Entrepreneur Of The Year(R) 2011 Award for the San Diego region. Slattery was selected as a semifinalist from nearly 165 nominations by a panel of independent judges. The Ernst & Young awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Award winners will be announced on June 16, 2011.

    (Photo: http://photos.prnewswire.com/prnh/20110425/LA88476) James Slattery launched Millennium Laboratories in late 2006 after a successful career that encompassed broadcast communications and real estate development.

    Under his direction as chief executive officer in less than five years the company has built a solid reputation as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education. A national network of physicians now uses Millennium Laboratories' services to increase patient safety and improve patient care for people experiencing chronic pain.

    Millennium Laboratories is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy. In 2010 the company established the Millennium Research Institute, a national, non-profit center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders.

    Millennium CEO James Slattery noted, "I am honored to have been selected as a semifinalist for the prestigious Ernst & Young Entrepreneur Of The Year award program. As a values-based organization, Millennium Laboratories places the needs of our physician network and their patients first. This is the cornerstone of our success and our reputation. The Ernst & Young acknowledgement is a direct outgrowth of the hard work, integrity and commitment to excellence of everyone on the Millennium team in establishing the gold standard in prescription drug monitoring." The Ernst & Young Entrepreneur Of The Year awards program celebrates its 25th anniversary this year. The program has expanded to recognize business leaders in over 140 cities and over 50 countries throughout the world.

    Regional award winners are eligible for consideration for the Ernst & Young LLP Entrepreneur Of The Year national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced at the annual awards gala in Palm Springs, California on November 12, 2011. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation's most prestigious gathering of high-growth, market-leading companies, and is held from November 9-13, 2011.

    About Millennium Laboratories Located in San Diego's life sciences cluster, Millennium Laboratories, Inc. is a national, research-based medication monitoring company whose test offerings, technology, customer support, educational resources and experts are specifically focused on clinicians who treat chronic pain. The company is recognized as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education. Millennium serves as an industry, government and payer educator and a compassionate advocate for pain sufferers throughout the United States. The company is accredited by The Joint Commission, receiving the Gold Seal of Approval(TM) for healthcare quality and safety.

    Among the numerous scientific and research achievements of the company's renowned laboratory team, Millennium Laboratories is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy.

    As part of the company's commitment to pain management research and education, Millennium Laboratories established the Millennium Research Institute (MRI), a non-profit, national research center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders. MRI maintains several national academic partnerships and supports collaborative research by accessing Millennium Laboratories' unique database representing the U.S. pain population. For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.

    About Ernst & Young's Entrepreneur Of The Year(R) Awards Program Ernst & Young's Entrepreneur Of The Year(R) is the world's most prestigious business award for entrepreneurs. The award makes a difference through the unique way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Ernst & Young Entrepreneur Of The Year(R) celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

    Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited located in the U.S.

    SOURCE Millennium Laboratories, Inc.

    www.prnewswire.com Copyright (C) 2011 PR Newswire. All rights reserved -0- KEYWORD: California INDUSTRY KEYWORD: HEA


  2. Anonymous

    Anonymous Guest

    Ok, and your point is?
  3. Anonymous

    Anonymous Guest

    Should be "crook of the year".
  4. Anonymous

    Anonymous Guest

    Why do you say that?
  5. Anonymous

    Anonymous Guest

    b/c charging some elderly person on a fixed income several hundreds of dollars for a pee test is unethical. All of these companies should be investigated for unfair practices and over billing medicare and medicaid.

    What goes around comes around.
  6. Anonymous

    Anonymous Guest

    Looks like this guy is going down. We heard OIG is investigating Millennium labs for fraudulent billing practices along with John Doe 1-10,000 whom are all their customers. Could get really nasty.
  7. Anonymous

    Anonymous Guest

    is this similar to the investigation we had and ended up paying 20 million. Its safe to say the whole industry is being looked at
  8. Anonymous

    Anonymous Guest

  9. Anonymous

    Anonymous Guest

    Correct. You cannot unbundle analytes for a single test.

    Many labs have made this mistake early in their life cycle, when they are run by people who have no lab or billing experience.

    Most of them make the mistake on GC or LC testing. The bill multiple units for the analytes tested for, even though it is one single sample prep, and one single analytical run.

    Doing this on a point of care cup that costs 5 bucks, and having the doctors billing multiple units is going to be very expensive for these labs, and for the doctors...

    Hope the "loan" from the Federal government was worth it. Triple damages can be levied against these people, especially since it was done with malice aforethought.
  10. Anonymous

    Anonymous Guest

    "Many physicians conduct drug testing at point of care; including Calloway’s customers. At the heart of this issue is Millennium’s position that physicians should be fairly reimbursed for performing drug testing at their point of care vs. the position that Calloway takes – that they should not,” Mr. Appel stated. "

    The above is a quote from Millennium's rebuttal: The point of Care Device costs an average of $7 and was billed for on average $300 without factoring staff time and billing time this is a 4200% profit margin with staff time and billing time the total costs is about $20.. this is a 1500% profit margin.. How is this a fair reimbursement for insurance companies that are funded by tax payers, companies and private citizens?
    I need to become a pain management physician if the "fair" reimbursements are like this, and for coming up with this program you are nominated for CEO of the year! WOW, I have just lost all faith / hope for healthcare in America...
  11. Anonymous

    Anonymous Guest

    Nice statement. You completely left off the part that as a company Millennium advocates physicians taking advantage of the system to profit $300 (1500%) and then the company itself takes advantage of a billing practice that allows them to illegally bill to collect $300 - 400 (500% profit) doubling the cost not only to the patient, the insurance company, but back to the tax paying citizen.
  12. Anonymous

    Anonymous Guest

    I have heard of a number of high level execs moving on as it is now clear that Millennium is not a candidate for a takeover at this time. The company is expected to survive, but it will not grow much from now on, and long-term prospects appear bleak.
  13. Anonymous

    Anonymous Guest

    Just curious how would you know this?
  14. Anonymous

    Anonymous Guest

    HAAHAAHAA! Dear Lord, this is going to be great comedy as the Grand Jury does their work. I would love to hold up a $5 piss cup, and the spreadsheet from your sales team showing how much a doctor can make with it, to a jury of taxpayers. You can claim the doctors knew what they were doing, but it's based on your "educational material". I can't wait for a civil suite from a large healthcare group to be filed against you. Perhaps it already has?.?.?.?......
  15. Anonymous

    Anonymous Guest

    This guy is a joke. He is a blight on the lab business and he thinks physicians are dumb. I heard him say it.
  16. anonymous

    anonymous Guest

    Took longer than we expected, but...

    "A group of owners, including Slattery, would provide most of the funds, while TA Associates would pay a minority share, they said. The current equity holders would provide funds to Millennium so it can pay the settlement reached this week with the U.S. Department of Justice over allegations of overbilling a federal health-care program and other matters, said the people."


    Private insurance is soon to be at your doorstep with torches and pitchforks. When they arrive, they will not knock to be let inside. They will not want to fund the airplane museum, I'm sure.

  17. anonymous

    anonymous Guest

    Orange jumpsuits are in style this fall.
  18. anonymous

    anonymous Guest

    No one going to jail and the arrogant, sue everyone jerk is going to keep at least 100 million.
    Fraud pays.